InvestorsHub Logo
Followers 0
Posts 88
Boards Moderated 0
Alias Born 07/15/2013

Re: None

Wednesday, 08/28/2013 12:58:22 PM

Wednesday, August 28, 2013 12:58:22 PM

Post# of 130514
For those who might be wondering WHY MANF PATENTS ARE CRITICAL TO AMBS?

During an email conversation with Jason Napodano, he told me the following:

"If AMBS owns the patents to MANF or the specific indication, then the outside groups can't do anything without AMBS' permission. Most of the time the outside groups are universities or other academic centers. They are not interested in selling the drug, only doing science to publish in peer-reviewed journals. 99 times out of 100 they are working with the company directly."